{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:53:37Z","timestamp":1793879617768,"version":"4.7.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":38,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.curtheres.2024.100737","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T12:08:54Z","timestamp":1714133334000},"page":"100737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"special_numbering":"C","title":["Biomarkers of Hepatic Toxicity: An Overview"],"prefix":"10.1016","volume":"100","author":[{"given":"Simran","family":"Thakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-7437","authenticated-orcid":false,"given":"Dinesh Kumar","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2024.100737_bib0001","series-title":"The Liver and Gallbladder Miracle Cleanse: An All-Natural, At-Home Flush to Purify and Rejuvenate Your Body","author":"Moritz","year":"2007"},{"key":"10.1016\/j.curtheres.2024.100737_bib0002","series-title":"Introduction to Clinical Nutrition","author":"Sardesai","year":"2011"},{"key":"10.1016\/j.curtheres.2024.100737_bib0003","first-page":"1","article-title":"Clinical biochemistry of hepatotoxicity","volume":"4","author":"Singh","year":"2011","journal-title":"J Clin Toxicol S"},{"issue":"6","key":"10.1016\/j.curtheres.2024.100737_bib0004","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug-induced liver disease","volume":"62","author":"Ramachandran","year":"2009","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Report of an International Consensus Meeting. Criteria of drug-induced liver disorders","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.curtheres.2024.100737_bib0006","series-title":"Clinical Cases in Hepatology","first-page":"27","article-title":"Primary biliary cholangitis","author":"Bergasa","year":"2022"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0007","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0168-8278(02)00231-3","article-title":"Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs","volume":"37","author":"Ib\u00e1\u00f1ez","year":"2002","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0008","first-page":"278","article-title":"An analysis of the causes, characteristics, and consequences of reexposure to a drug or compound responsible for a hepatotoxicity event","volume":"100","author":"Fern\u00e1ndez-Casta\u00f1er","year":"2008","journal-title":"Rev Esp Enferm Digest"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0009","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.curtheres.2024.100737_bib0010","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0011","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/tx200320e","article-title":"Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?","volume":"25","author":"Zhang","year":"2012","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0012","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.curtheres.2024.100737_bib0013","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic","volume":"24","author":"De Valle","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Acute and clinically relevant drug-induced liver injury: a population based case-control study","volume":"58","author":"De Abajo","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.curtheres.2024.100737_bib0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.curtheres.2024.100737_bib0016","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in mainland China","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.curtheres.2024.100737_bib0017","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0018","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/hep.20081","article-title":"Hy's law","volume":"39","author":"Reuben","year":"2004","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.curtheres.2024.100737_bib0019","doi-asserted-by":"crossref","first-page":"876","DOI":"10.5858\/arpa.2014-0214-RA","article-title":"Drug-induced liver injury","volume":"139","author":"Fisher","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/apt.12569","article-title":"Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease\u2013the role of transient elastography and plasma cytokeratin-18 fragments","volume":"39","author":"Kwok","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0021","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/03602532.2011.604086","article-title":"Central role of mitochondria in drug-induced liver injury","volume":"44","author":"Pessayre","year":"2012","journal-title":"Drug Metab Rev"},{"issue":"196","key":"10.1016\/j.curtheres.2024.100737_bib0022","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-642-00663-0_11","article-title":"Mitochondrial involvement in drug-induced liver injury","author":"Pessayre","year":"2010","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0023","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1939-165X.2005.tb00041.x","article-title":"Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies","volume":"34","author":"Boone","year":"2005","journal-title":"Vet Clin Pathol"},{"key":"10.1016\/j.curtheres.2024.100737_bib0024","series-title":"Animal Clinical Chemistry: A Practical Handbook for Toxicologists and Biomedical Researchers","author":"Evans","year":"2009"},{"issue":"4","key":"10.1016\/j.curtheres.2024.100737_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1211","article-title":"Hy's law: predicting serious hepatotoxicity","volume":"15","author":"Temple","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.curtheres.2024.100737_bib0026","series-title":"Biomarkers in Liver Disease","first-page":"1012","article-title":"Traditional markers in liver disease","author":"Derosa","year":"2017"},{"key":"10.1016\/j.curtheres.2024.100737_bib0027","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12098-007-0118-7","article-title":"Liver function tests and their interpretation","volume":"74","author":"Thapa","year":"2007","journal-title":"Indian J Pediatr"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0028","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0029","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jmb.2011.07.034","article-title":"Molecular modeling and functional confirmation of a predicted fatty acid binding site of mitochondrial aspartate aminotransferase","volume":"412","author":"Bradbury","year":"2011","journal-title":"J Mol Biol"},{"issue":"17","key":"10.1016\/j.curtheres.2024.100737_bib0030","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients","volume":"342","author":"Pratt","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0031","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.atherosclerosis.2015.09.006","article-title":"Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: the PREVEND study","volume":"243","author":"Kunutsor","year":"2015","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0032","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"9663","key":"10.1016\/j.curtheres.2024.100737_bib0033","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.curtheres.2024.100737_bib0034","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.curtheres.2024.100737_bib0035","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2007.07.022","article-title":"The clinical significance of persistently normal ALT in chronic hepatitis B infection","volume":"47","author":"Lai","year":"2007","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0036","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1053\/j.gastro.2004.02.073","article-title":"Chronic hepatitis C with normal aminotransferase levels","volume":"126","author":"Ahmed","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0037","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hep.24725","article-title":"Upper limits of normal for alanine aminotransferase activity in the United States population","volume":"55","author":"Ruhl","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0038","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1053\/jhep.2003.50344","article-title":"Dynamics of alanine aminotransferase during hepatitis C virus treatment","volume":"38","author":"Ribeiro","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0039","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.curtheres.2024.100737_bib0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-8278(00)80420-1","article-title":"Alcoholic liver disease: new insights in pathogenesis lead to new treatments","volume":"32","author":"Lieber","year":"2000","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.curtheres.2024.100737_bib0041","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.dld.2010.04.001","article-title":"Risk factors for serum alanine aminotransferase elevation: a cross-sectional study of healthy adult males in Tokyo, Japan","volume":"42","author":"Gunji","year":"2010","journal-title":"Digest Liver Dis"},{"issue":"9","key":"10.1016\/j.curtheres.2024.100737_bib0042","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7150\/ijms.8951","article-title":"Alanine aminotransferase-old biomarker and new concept: a review","volume":"11","author":"Liu","year":"2014","journal-title":"Int J Med Sci"},{"issue":"4","key":"10.1016\/j.curtheres.2024.100737_bib0043","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ajcn\/88.4.1097","article-title":"Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index","volume":"88","author":"Alatalo","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"19","key":"10.1016\/j.curtheres.2024.100737_bib0044","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1001\/jama.287.19.2559","article-title":"Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial","volume":"287","author":"Davies","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/alcalc\/agg051","article-title":"Joint use of clinical parameters, biological markers and CAGE questionnaire for the identification of heavy drinkers in a large population-based sample","volume":"38","author":"Bataille","year":"2003","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0046","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1530-0277.2002.tb02542.x","article-title":"CDT, GGT, and AST as markers of alcohol use: the WHO\/ISBRA collaborative project","volume":"26","author":"Conigrave","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"issue":"1-2","key":"10.1016\/j.curtheres.2024.100737_bib0047","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jchromb.2006.05.005","article-title":"Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001\u20132005","volume":"841","author":"Bortolotti","year":"2006","journal-title":"J Chromatogr B"},{"issue":"33","key":"10.1016\/j.curtheres.2024.100737_bib0048","doi-asserted-by":"crossref","first-page":"11684","DOI":"10.3748\/wjg.v20.i33.11684","article-title":"Diagnosis of alcoholic liver disease","volume":"20","author":"Torruellas","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.curtheres.2024.100737_bib0049","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/alcalc\/agg113","article-title":"Combining carbohydrate-deficient transferrin and gamma-glutamyltransferase to increase diagnostic accuracy for problem drinking","volume":"38","author":"Chen","year":"2003","journal-title":"Alcohol Alcohol"},{"issue":"8","key":"10.1016\/j.curtheres.2024.100737_bib0050","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1530-0277.2009.00974.x","article-title":"Cost-effectiveness of screening for unhealthy alcohol use with% carbohydrate deficient transferrin: results from a literature-based decision analytic computer model","volume":"33","author":"Kapoor","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0051","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ajg.2008.149","article-title":"How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial","volume":"104","author":"Laine","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.curtheres.2024.100737_bib0052","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2007.03330.x","article-title":"The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury","volume":"25","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.curtheres.2024.100737_bib0053","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/ije\/dyr172","article-title":"The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes","volume":"40","author":"Ford","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1016\/j.curtheres.2024.100737_bib0054","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0002-9149(02)02355-X","article-title":"The liver and lovastatin","volume":"89","author":"Tolman","year":"2002","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0055","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0056","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.20689","article-title":"Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town","volume":"41","author":"Pendino","year":"2005","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.curtheres.2024.100737_bib0057","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1440-1746.2006.04615.x","article-title":"Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan","volume":"22","author":"Chen","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.curtheres.2024.100737_bib0058","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3748\/wjg.v11.i11.1616","article-title":"A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan","volume":"11","author":"Liu","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0059","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2174\/2212796814999201111204639","article-title":"Serum biomarkers for noninvasive diagnosis of liver diseases: how laudable are these tools?","volume":"15","author":"Singh","year":"2021","journal-title":"Curr Chem Biol"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/011542650702200101","article-title":"Nonalcoholic fatty liver disease and obesity","volume":"22","author":"Saadeh","year":"2007","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.curtheres.2024.100737_bib0061","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and natural history of NAFLD and NASH","volume":"11","author":"Ong","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0063","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00000441-200503000-00001","article-title":"Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III)","volume":"329","author":"Liangpunsakul","year":"2005","journal-title":"Am J Med Sci"},{"issue":"12","key":"10.1016\/j.curtheres.2024.100737_bib0064","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0065","first-page":"215","article-title":"Bile metabolism and lithogenesis: an update","volume":"99","author":"Dosch","year":"2019","journal-title":"Surg Clin"},{"key":"10.1016\/j.curtheres.2024.100737_bib0066","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1478-3231.2008.01716.x","article-title":"Bilirubin in clinical practice: a review","volume":"28","author":"Fevery","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.curtheres.2024.100737_bib0067","series-title":"Guidance for Industry. Drug-induced Liver Injury","year":"2009"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0068","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.curtheres.2024.100737_bib0069","first-page":"15930","article-title":"Prognostic value of total bilirubin in patients with angina pectoris undergoing percutaneous coronary intervention","volume":"8","author":"Yao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.curtheres.2024.100737_bib0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12012-017-9405-3","article-title":"Association of fasting serum bilirubin levels with clinical outcomes after percutaneous coronary intervention: a prospective study","volume":"17","author":"Zhang","year":"2017","journal-title":"Cardiovasc Toxicol"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0071","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1536\/ihj.51.86","article-title":"Serum bilirubin concentration in patients with an established coronary artery disease","volume":"51","author":"Ghem","year":"2010","journal-title":"Int Heart J"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0072","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.25551","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011","volume":"55","author":"Lee","year":"2012","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.curtheres.2024.100737_bib0074","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1155\/2015\/818570","article-title":"Gamma-glutamyltransferase: a predictive biomarker of cellular antioxidant inadequacy and disease risk","volume":"2015","author":"Koenig","year":"2015","journal-title":"Dis Markers"},{"issue":"4","key":"10.1016\/j.curtheres.2024.100737_bib0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/20014091084227","article-title":"Gamma glutamyl transferase","volume":"38","author":"Whitfield","year":"2001","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"9","key":"10.1016\/j.curtheres.2024.100737_bib0076","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/ATVBAHA.110.207340","article-title":"Serum \u03b3-glutamyl transferase and risk of heart failure in the community","volume":"30","author":"Dhingra","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1-2","key":"10.1016\/j.curtheres.2024.100737_bib0077","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mrfmmm.2009.05.010","article-title":"Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells","volume":"669","author":"Corti","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.curtheres.2024.100737_bib0078","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02912899","article-title":"Effect of Vitex negundo leaf extract on the free radicals scavengers in complete Freund's adjuvant induced arthritic rats","volume":"22","author":"Devi","year":"2007","journal-title":"Indian J Clin Biochem"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0079","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1034\/j.1600-0609.2002.01636.x","article-title":"Erythrocytes as targets for gamma-glutamyltranspeptidase initiated pro-oxidant reaction","volume":"68","author":"Aberkane","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.curtheres.2024.100737_bib0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.12659\/AOT.894289","article-title":"Nitric oxide regulation of mitochondrial processes: commonality in medical disorders","volume":"20","author":"Stefano","year":"2015","journal-title":"Ann Transplant"},{"issue":"14","key":"10.1016\/j.curtheres.2024.100737_bib0081","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/CIRCULATIONAHA.105.571919","article-title":"Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque","volume":"112","author":"Emdin","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.curtheres.2024.100737_bib0082","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1515\/CCLM.2004.224","article-title":"The significance of serum \u03b3-glutamyltransferase in cardiovascular diseases","volume":"42","author":"Pompella","year":"2004","journal-title":"Clin Chem Lab Med"},{"issue":"Suppl","key":"10.1016\/j.curtheres.2024.100737_bib0083","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.21101\/cejph.a3901","article-title":"Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study","volume":"22","author":"Jar\u010du\u0161ka","year":"2014","journal-title":"Cent Eur J Public Health"},{"issue":"6","key":"10.1016\/j.curtheres.2024.100737_bib0084","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1590-8658(04)00094-5","article-title":"Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver","volume":"36","author":"Loguercio","year":"2004","journal-title":"Digest Liver Dis"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0085","first-page":"54","article-title":"The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis","volume":"36","author":"Fishbein","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0086","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1538-7836.2008.02935.x","article-title":"Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population","volume":"6","author":"Kain","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.curtheres.2024.100737_bib0087","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1503\/cmaj.045232","article-title":"Nonalcoholic fatty liver disease","volume":"172","author":"Adams","year":"2005","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0088","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-020-01369-x","article-title":"Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study","volume":"20","author":"Fujii","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0089","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000519752","article-title":"Marked increase of gamma-glutamyltransferase as an indicator of drug-induced liver injury in patients without conventional diagnostic criteria of acute liver injury","volume":"38","author":"Weber","year":"2022","journal-title":"Visc Med"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1573403X14666181031141226","article-title":"Tissue non-specific alkaline phosphatase and vascular calcification: a potential therapeutic target","volume":"15","author":"Azpiazu","year":"2019","journal-title":"Curr Cardiol Rev"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0091","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000011","article-title":"Recent advances with alkaline phosphatase isoenzymes and their inhibitors","volume":"353","author":"Zaher","year":"2020","journal-title":"Arch Pharm (Weinheim)"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0092","first-page":"478","article-title":"Quantification and comparison of bone-specific alkaline phosphatase with two methods in normal and Paget's specimens","volume":"3","author":"Masrour Roudsari","year":"2012","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.curtheres.2024.100737_bib0093","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12291-013-0408-y","article-title":"Alkaline phosphatase: an overview","volume":"29","author":"Sharma","year":"2014","journal-title":"Indian J Clin Biochem"},{"issue":"8","key":"10.1016\/j.curtheres.2024.100737_bib0094","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.top100768","article-title":"Alkaline phosphatase","volume":"2020","author":"Green","year":"2020","journal-title":"Cold Spring Harb Protoc"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-2-2","article-title":"High serum alkaline phosphatase levels, a study in 181 Thai adult hospitalized patients","volume":"2","author":"Wiwanitkit","year":"2001","journal-title":"BMC Fam Pract"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0096","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229753","article-title":"Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments","volume":"15","author":"Schomaker","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0097","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cld.562","article-title":"Standard liver tests","volume":"8","author":"Kasarala","year":"2016","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.curtheres.2024.100737_bib0098","series-title":"Implications of Sex and Extra-Hepatic Ammonia Metabolism in Chronic Liver Disease and Development of Hepatic Encephalopathy","first-page":"130","author":"Macedo de Oliveira","year":"2022"},{"issue":"1-2","key":"10.1016\/j.curtheres.2024.100737_bib0099","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jnr.20353","article-title":"Molecular basis of human glutamate dehydrogenase regulation under changing energy demands","volume":"79","author":"Mastorodemos","year":"2005","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0100","first-page":"61","article-title":"Biomarkers of mitotoxicity after acute liver injury: further insights into the interpretation of glutamate dehydrogenase","volume":"7","author":"McGill","year":"2021","journal-title":"J Clin Transl Res"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0101","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1542\/peds.2010-0929","article-title":"Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy","volume":"127","author":"McMillan","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.curtheres.2024.100737_bib0102","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijbiomac.2017.11.141","article-title":"Unique properties of arginase purified from camel liver cytosol","volume":"108","author":"Maharem","year":"2018","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"10.1016\/j.curtheres.2024.100737_bib0103","first-page":"1430","article-title":"L-arginase: a medically important enzyme","volume":"6","author":"Kumar","year":"2013","journal-title":"Res J Pharm Technol"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0104","doi-asserted-by":"crossref","first-page":"465","DOI":"10.18388\/abp.2009_2481","article-title":"Arginase isoenzymes in human cirrhotic liver","volume":"56","author":"Chrzanowska","year":"2009","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"10.1016\/j.curtheres.2024.100737_bib0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/msy.2000.104745","article-title":"Trauma increases extrahepatic arginase activity","volume":"127","author":"Ochoa","year":"2000","journal-title":"Surgery"},{"issue":"1-2","key":"10.1016\/j.curtheres.2024.100737_bib0106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2006.06.018","article-title":"Advantage of serum type-I arginase and ornithine carbamoyltransferase in the evaluation of acute and chronic liver damage induced by thioacetamide in rats","volume":"375","author":"Murayama","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0107","first-page":"58","article-title":"Clinical significance of arginase after liver transplantation","volume":"9","author":"Ashamiss","year":"2004","journal-title":"Ann Transplant"},{"issue":"3-4","key":"10.1016\/j.curtheres.2024.100737_bib0108","first-page":"209","article-title":"Diagnostic value of alpha-glutathione S-transferase as a sensitive marker of increased risk for hepatocellular damage in hepatitis C virus (HCV) infection: relation to HCV viraemia","volume":"78","author":"Helaly","year":"2003","journal-title":"J Egypt Public Health Assoc"},{"key":"10.1016\/j.curtheres.2024.100737_bib0109","first-page":"44","article-title":"Blood serum glutathione alpha s-transferase (alpha GST) activity during antiviral therapy in patients with chronic hepatitis C","volume":"9","author":"Mazur","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.curtheres.2024.100737_bib0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1155\/2019\/5850787","article-title":"Plasma \u03b1-glutathione S-transferase evaluation in patients with acute and chronic liver injury","volume":"2019","author":"Czuczejko","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2350-11-46","article-title":"Glutathione S-transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma","volume":"11","author":"Chen","year":"2010","journal-title":"BMC Med Genet"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119481","article-title":"Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case\u2013control study","volume":"10","author":"He","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0113","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archsurg.135.2.198","article-title":"Plasma \u03b1-glutathione S-transferase: a sensitive indicator of hepatocellular damage during polymicrobial sepsis","volume":"135","author":"Koo","year":"2000","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.curtheres.2024.100737_bib0114","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1460-9592.2000.00511.x","article-title":"Serum glutathione S-transferase alpha as a measure of hepatocellular function following prolonged anaesthesia with sevoflurane and halothane in paediatric patients","volume":"10","author":"Iwanaga","year":"2000","journal-title":"Pediatr Anesth"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0115","first-page":"13","article-title":"Significance of serum alpha-glutathione S-transferase assessment in hepatitis C patients with different alanine aminotransferase patterns","volume":"4","author":"Abdel-Moneim","year":"2011","journal-title":"Gastroenterol Res"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0116","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/01926230252929945","article-title":"Alpha-glutathione S-transferase in the assessment of hepatotoxicity\u2014its diagnostic utility in comparison with other recognized markers in the Wistar Han rat","volume":"30","author":"Giffen","year":"2002","journal-title":"Toxicol Pathol"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0117","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.imlet.2013.05.002","article-title":"Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients","volume":"152","author":"Yue","year":"2013","journal-title":"Immunol Lett"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0118","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","article-title":"The current state of serum biomarkers of hepatotoxicity","volume":"245","author":"Ozer","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.curtheres.2024.100737_bib0119","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/chemosensors10080326","article-title":"Optical immunoassays methods in protein analysis: an overview","volume":"10","author":"Rizzo","year":"2022","journal-title":"Chemosensors"},{"key":"10.1016\/j.curtheres.2024.100737_bib0120","unstructured":"Dolz P\u00e9rez, Irene, et al. Development of polypeptide-based therapeutics for topical delivery, 26 nov 2019-Teseo:608993 https:\/\/hdl.handle.net\/10550\/72220"},{"issue":"14","key":"10.1016\/j.curtheres.2024.100737_bib0121","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1093\/emboj\/20.14.3840","article-title":"Synthesis of a novel hepatitis C virus protein by ribosomal frameshift","volume":"20","author":"Xu","year":"2001","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0122","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1440-1746.2000.02066.x","article-title":"Amino acid substitutions in codons 9\u201311 of hepatitis C virus core protein lead to the synthesis of a short core protein product","volume":"15","author":"Yeh","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0123","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1017\/S1355838201010111","article-title":"Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame","volume":"7","author":"Walewski","year":"2001","journal-title":"RNA"},{"issue":"7","key":"10.1016\/j.curtheres.2024.100737_bib0124","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/iub.201","article-title":"The HCV ARFP\/F\/core+ 1 protein: production and functional analysis of an unconventional viral product","volume":"61","author":"Vassilaki","year":"2009","journal-title":"IUBMB Life"},{"issue":"Pt 7","key":"10.1016\/j.curtheres.2024.100737_bib0125","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1099\/vir.0.19065-0","article-title":"Characterization of the expression of the hepatitis C virus F protein","volume":"84","author":"Roussel","year":"2003","journal-title":"J Gen Virol"},{"issue":"11","key":"10.1016\/j.curtheres.2024.100737_bib0126","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1128\/JCM.00612-08","article-title":"Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin","volume":"46","author":"Gao","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.curtheres.2024.100737_sbref0127","series-title":"Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics","first-page":"1075 pp","author":"Lopez","year":"2015"},{"key":"10.1016\/j.curtheres.2024.100737_bib0128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1155\/2016\/5120760","article-title":"Albumin binding function: the potential earliest indicator for liver function damage","volume":"2016","author":"Ge","year":"2016","journal-title":"Gastroenterol Res Pract"},{"issue":"9","key":"10.1016\/j.curtheres.2024.100737_bib0129","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.curtheres.2024.100737_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fcimb.2022.721138","article-title":"High albumin level is associated with regression of glucose metabolism disorders upon resolution of acute liver inflammation in hepatitis B-related cirrhosis","volume":"12","author":"Tian","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0131","first-page":"149","article-title":"Noninvasive biochemical markers of liver fibrosis","volume":"15","author":"Grigorescu","year":"2006","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.curtheres.2024.100737_bib0132","first-page":"66","article-title":"Blood coagulation factors and platelet response to drug-induced hepatitis and hepatosis in rats","author":"Korolova","year":"2022","journal-title":"Animal Model Exp Med"},{"issue":"4","key":"10.1016\/j.curtheres.2024.100737_bib0133","article-title":"Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis","volume":"2","author":"Zermatten","year":"2020","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0134","doi-asserted-by":"crossref","first-page":"107","DOI":"10.18231\/2394-6792.2019.0019","article-title":"A study of coagulation profile in diseases of liver: at tertiary care center hospital","volume":"6","author":"Kotadiya","year":"2019","journal-title":"Indian J Pathol Oncol"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.33545\/pathol.2020.v3.i3c.280","article-title":"Coagulation profile in liver diseases: A study of 250 cases in a tertiary care hospital","volume":"3","author":"Prajapati","year":"2020","journal-title":"Int J Clin Diagn Pathol"},{"key":"10.1016\/j.curtheres.2024.100737_bib0136","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00281-012-0356-2","article-title":"Lipids and HCV","volume":"35","author":"Bassendine","year":"2013","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.curtheres.2024.100737_bib0137","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1542-3565(04)00622-6","article-title":"High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics","volume":"3","author":"Habib","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0138","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-2004-832941","article-title":"Nutrition and alcoholic liver disease","volume":"24","author":"Halsted","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.curtheres.2024.100737_bib0139","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000102155","article-title":"Impact of viral hepatitis on apo- and lipoprotein status in blood","volume":"16","author":"Irshad","year":"2007","journal-title":"Med Princ Pract"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2893.2005.00655.x","article-title":"Serum lipid pattern in chronic hepatitis C: histological and virological correlations","volume":"13","author":"Siagris","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.curtheres.2024.100737_bib0141","first-page":"285","article-title":"The relationship between lipid profile and severity of liver damage in cirrhotic patients","volume":"10","author":"Ghadir","year":"2010","journal-title":"Hepat Mon"},{"key":"10.1016\/j.curtheres.2024.100737_bib0142","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0168-8278(02)00199-X","article-title":"Haemostatic abnormalities in patients with liver disease","volume":"37","author":"Lisman","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.curtheres.2024.100737_bib0143","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.curtheres.2024.100737_bib0144","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jhep.2011.06.008","article-title":"Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?","volume":"55","author":"Violi","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.curtheres.2024.100737_bib0145","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V95.3.795.003k25_795_801","article-title":"Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production","volume":"95","author":"Peck-Radosavljevic","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.curtheres.2024.100737_bib0146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2017.05.009","article-title":"Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats","volume":"386","author":"Slopianka","year":"2017","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193824","article-title":"Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans","volume":"13","author":"Luo","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0148","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/hep.29153","article-title":"Hepatic mitochondrial DNA\/toll-like receptor 9\/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation acetaminophen hepatotoxicity in mice","volume":"66","author":"He","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0149","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S2468-1253(17)30266-2","article-title":"Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies","volume":"3","author":"Dear","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0150","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/jcm4051063","article-title":"MicroRNAs as signaling mediators and biomarkers of drug- and chemical-induced liver injury","volume":"4","author":"McGill","year":"2015","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0151","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.gde.2005.08.007","article-title":"HMG proteins: dynamic players in gene regulation and differentiation","volume":"15","author":"Bianchi","year":"2005","journal-title":"Curr Opin Genet Dev"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0152","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J","article-title":"Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis","volume":"187","author":"Leers","year":"1999","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0153","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.26294","article-title":"Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital","volume":"58","author":"Antoine","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100737_bib0154","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/1354750X.2014.897757","article-title":"Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans","volume":"19","author":"McGill","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.curtheres.2024.100737_bib0155","first-page":"5","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: an international collaborative effort","author":"Church","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0156","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/liv.13174","article-title":"Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury","volume":"37","author":"Mikus","year":"2017","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100737_bib0157","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1021\/acs.jproteome.6b00547","article-title":"Identification of organ-enriched protein biomarkers of acute liver injury by targeted quantitative proteomics of blood in acetaminophen- and carbon-tetrachloride-treated mouse models and acetaminophen overdose patients","volume":"15","author":"Qin","year":"2016","journal-title":"J Proteome Res"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100737_bib0158","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1124\/dmd.121.000732","article-title":"Novel clinical biomarkers for drug-induced liver injury","volume":"50","author":"Chen","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.curtheres.2024.100737_bib0159","first-page":"311","article-title":"Aspartate aminotransferase and cardiovascular disease\u2014a narrative review","volume":"6","author":"Ndrepepa","year":"2021","journal-title":"J Lab Precis Med"},{"issue":"Suppl 2","key":"10.1016\/j.curtheres.2024.100737_bib0160","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1086\/381446","article-title":"Drug-induced liver injury","volume":"38","author":"Kaplowitz","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0161","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1081\/DMR-120034148","article-title":"Clinical perspectives on xenobiotic-induced hepatotoxicity","volume":"36","author":"Gunawan","year":"2004","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100737_bib0162","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"issue":"9262","key":"10.1016\/j.curtheres.2024.100737_bib0163","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T05:29:13Z","timestamp":1730957353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X24000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":162,"alternative-id":["S0011393X24000079"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100737","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of Hepatic Toxicity: An Overview","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100737"}}